These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198 [Abstract] [Full Text] [Related]
14. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab. Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S, Post-Injection Endophthalmitis (PIE) Study Group. Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891 [Abstract] [Full Text] [Related]
17. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA. Retina; 2013 Mar; 33(7):1407-16. PubMed ID: 23492945 [Abstract] [Full Text] [Related]